We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

165 hedge funds and large institutions have $733M invested in Spectrum Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 82 increasing their positions, 27 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

204% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 27

5% less funds holding

Funds holding: 173 → 165 (-8)

17% less capital invested

Capital invested by funds: $881M → $733M (-$147M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

97% less call options, than puts

Call options by funds: $342K | Put options by funds: $13.6M

Holders
165
Holders Change
-8
Holders Change %
-4.62%
% of All Funds
3.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
82
Reduced
27
Closed
23
Calls
$342K
Puts
$13.6M
Net Calls
-$13.2M
Net Calls Change
-$12.3M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$9.25M
2
N
Nuveen
North Carolina
+$6.99M
3
BlackRock
BlackRock
New York
+$6.96M
4
Morgan Stanley
Morgan Stanley
New York
+$5.66M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$20.6M
2
Millennium Management
Millennium Management
New York
-$9.17M
3
Bank of America
Bank of America
North Carolina
-$3.03M
4
State Street
State Street
Massachusetts
-$2.83M
5
Invesco
Invesco
Georgia
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$151M +$6.96M +778,654 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$103M +$5.18M +579,500 +5%
Primecap Management
3
Primecap Management
California
$95.8M +$599K +67,000 +0.6%
State Street
4
State Street
Massachusetts
$44M -$2.83M -316,908 -6%
ACH
5
ArrowMark Colorado Holdings
Colorado
$32.6M +$2.3M +256,972 +7%
Macquarie Group
6
Macquarie Group
Australia
$25.4M +$1.76M +196,320 +7%
Renaissance Technologies
7
Renaissance Technologies
New York
$23.5M +$9.25M +1,034,135 +61%
Norges Bank
8
Norges Bank
Norway
$20.9M +$4.32M +482,688 +25%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$17.8M -$613K -68,548 -3%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$12.2M +$1.22M +136,312 +11%
Northern Trust
11
Northern Trust
Illinois
$11.1M +$235K +26,251 +2%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$10.6M +$1.93M +215,734 +21%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$10.4M +$194K +21,727 +2%
CS
14
Candriam SCA
Luxembourg
$9.15M +$201K +22,500 +2%
Morgan Stanley
15
Morgan Stanley
New York
$8.22M +$5.66M +632,303 +196%
Principal Financial Group
16
Principal Financial Group
Iowa
$7.61M +$55.2K +6,167 +0.7%
VOYA Investment Management
17
VOYA Investment Management
Georgia
$7.27M +$4.73M +528,759 +168%
Citadel Advisors
18
Citadel Advisors
Florida
$7.06M +$4.27M +476,983 +139%
Deutsche Bank
19
Deutsche Bank
Germany
$7.05M +$3.46M +387,336 +90%
N
20
Nuveen
North Carolina
$6.73M +$6.99M +781,921 New
Invesco
21
Invesco
Georgia
$6.38M -$2.32M -259,096 -26%
SIM
22
Sonora Investment Management
Arizona
$6.04M -$111K -12,385 -2%
Wells Fargo
23
Wells Fargo
California
$5.77M +$18K +2,007 +0.3%
Charles Schwab
24
Charles Schwab
California
$5.48M +$333K +37,173 +6%
SCM
25
Sio Capital Management
New York
$5.2M +$447K +50,000 +9%
1
2 3 4 5

SPPI Hedge Fund Activity: Q2 2019 in Review

165 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2019, worth a combined $733M — down 17% from $881M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SPPI and 17 opened new positions — a net loss of 6 holders — while 27 trimmed existing stakes and 82 added.

The largest buyer was Renaissance Technologies, adding an estimated $9.25M. The largest seller was Armistice Capital, exiting entirely with an estimated $20.6M sold.

  • 165 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2019, down from 173 in Q1 2019.
  • Funds reported $733M of Spectrum Pharmaceuticals Inc stock for Q2 2019, down 17% quarter-over-quarter.
  • 17 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of -6 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2019 was Renaissance Technologies, an estimated $9.25M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2019 was Armistice Capital, an estimated $20.6M sold.

Based on aggregated 13F filings for Q2 2019.